Joining ImmuONE: Insights from Jo
In our most recent coffee chat, we caught up with Jo Kelsall, our new lead commercial scientist. Jo shared with us her unique career…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse quis nibh eget urna placerat dictum in ac mauris. Etiam pellentesque tristique pretium.
In our most recent coffee chat, we caught up with Jo Kelsall, our new lead commercial scientist. Jo shared with us her unique career…
Dr Abigail Martin and Professor Victoria Hutter have secured backing from the MEIF Proof of Concept & Early Stage Fund, which is managed by…
In our latest coffee chat, we had the pleasure of sitting down with Rhamiya Mahendran, an Application Scientist at ImmuONE…
Inhaled substances are primarily tested on rats for toxicity, but key differences between rat and human lungs suggest it’s time to look towards alternative…
morph_ONE is a reproducible, mechanistic-driven assay that reveals how inhaled substances affect more than a dozen morphological and biochemical features of alveolar macrophages. The…
Further development of the ImmuPHAGE™ model has been the focus of Amjad’s work during his…
At ImmuONE, we believe in fostering the growth and development of young talents in the field of biotechnology….
More than half of aerosol medicines under development are terminated due to safety concerns. ImmuONE’s high content imaging or cell painting assays are proven…
Q: What attracted you to ImmuONE as a company? A: I was initially drawn to ImmuONE because of my positive experience during my final…